{"transactions":[{"id":731251,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-22T20:22:23.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"derivative":{"exercise_price":1.18,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001437749-26-021323","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021323/rdgdoc.xml","form_type":"4"}},{"id":1016129,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-20T13:11:05.000Z","date":"2025-10-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.5498,"value":5498.0,"ownership":{"direct":true},"balance_after":21402,"source":{"system":"sec-edgar","filing":"0001437749-25-031314","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925031314/rdgdoc.xml","form_type":"4"}},{"id":1120469,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-06T13:45:09.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":10000,"derivative":{"exercise_price":2.48,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-019634","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019634/rdgdoc.xml","form_type":"4"}},{"id":1173654,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-11T17:23:33.000Z","date":"2025-04-10","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.98,"value":9800.0,"ownership":{"direct":true},"balance_after":11402,"source":{"system":"sec-edgar","filing":"0001437749-25-011750","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925011750/rdgdoc.xml","form_type":"4"}},{"id":1434189,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-08-14T20:06:04.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":8050,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8050,"derivative":{"exercise_price":2.17,"exercise_date":"2025-08-12","expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":8050},"source":{"system":"sec-edgar","filing":"0001437749-24-026786","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026786/rdgdoc.xml","form_type":"4"}},{"id":1809185,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-08-14T20:53:51.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":50000,"derivative":{"exercise_price":0.755,"exercise_date":"2023-12-07","expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-23-023746","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023746/rdgdoc.xml","form_type":"4"}},{"id":2481333,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:24:20.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":3.82,"exercise_date":"2022-12-07","expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-028134","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921028134/rdgdoc.xml","form_type":"4"}},{"id":2607652,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:31:57.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":25000,"derivative":{"exercise_price":2.79,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-019503","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921019503/rdgdoc.xml","form_type":"4"}},{"id":2760818,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T20:03:45.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":319,"price":19.57,"value":6242.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $19.57 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2021."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 23,219 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":24361,"source":{"system":"sec-edgar","filing":"0001420506-21-000377","document":"doc4_919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000377/doc4_919.xml","form_type":"4"}},{"id":2925331,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T23:34:06.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":208,"price":15,"value":3120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $15.00 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 22,900 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":24042,"source":{"system":"sec-edgar","filing":"0001420506-21-000007","document":"doc4_891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000007/doc4_891.xml","form_type":"4"}},{"id":3018424,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T22:09:53.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":547,"price":5.71,"value":3123.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.71 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 22,692 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":23834,"source":{"system":"sec-edgar","filing":"0001420506-20-001035","document":"doc4_861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620001035/doc4_861.xml","form_type":"4"}},{"id":3021258,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock Purchase Warrant","published_at":"2020-09-29T22:27:27.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":21024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":21024,"derivative":{"exercise_price":5,"exercise_date":"2020-09-29","expiration_date":"2025-09-29","underlying":"Common Stock","underlying_shares":21024},"source":{"system":"sec-edgar","filing":"0001437749-20-020451","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020451/rdgdoc.xml","form_type":"4"}},{"id":3021257,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-09-29T22:27:27.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":21024,"price":5,"value":105120.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":21024,"source":{"system":"sec-edgar","filing":"0001437749-20-020451","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020451/rdgdoc.xml","form_type":"4"}},{"id":3091397,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T16:56:21.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":879,"price":3.55,"value":3120.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.55 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 30, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 22,145 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":23287,"source":{"system":"sec-edgar","filing":"0001171520-20-000282","document":"doc4_821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152020000282/doc4_821.xml","form_type":"4"}},{"id":3106745,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-06-17T20:10:14.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2021 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":4.13,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001420506-20-000691","document":"doc4_812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000691/doc4_812.xml","form_type":"4"}},{"id":3186154,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T20:10:04.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":875,"price":3.57,"value":3123.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.57 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 21,266 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":22408,"source":{"system":"sec-edgar","filing":"0001420506-20-000356","document":"doc4_798.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000356/doc4_798.xml","form_type":"4"}},{"id":3326942,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T22:06:11.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":630,"price":4.96,"value":3124.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $4.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 20,391 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":21533,"source":{"system":"sec-edgar","filing":"0001420506-20-000011","document":"doc4_784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000011/doc4_784.xml","form_type":"4"}},{"id":3402799,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-01T20:13:16.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":667,"price":5.15,"value":3435.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.15 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 19,761 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":20903,"source":{"system":"sec-edgar","filing":"0001534424-19-000274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000274/ownership.xml","form_type":"4"}},{"id":3474555,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-01T20:13:55.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":1085,"price":3.17,"value":3439.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.17 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 28, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 19,094 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":20236,"source":{"system":"sec-edgar","filing":"0001534424-19-000200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000200/ownership.xml","form_type":"4"}},{"id":3495656,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-06-10T20:11:59.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2020 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":3.25,"expiration_date":"2029-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-19-000177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000177/ownership.xml","form_type":"4"}},{"id":3568147,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T20:05:21.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":1092,"price":3.15,"value":3439.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.15 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 29, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 18,009 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":19151,"source":{"system":"sec-edgar","filing":"0001534424-19-000098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000098/ownership.xml","form_type":"4"}},{"id":3712936,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T22:06:22.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":2338,"price":1.47,"value":3436.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $1.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 16,917 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":18059,"source":{"system":"sec-edgar","filing":"0001534424-19-000009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000009/ownership.xml","form_type":"4"}},{"id":3725678,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:39:51.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":345000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":345000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":345000},"source":{"system":"sec-edgar","filing":"0001437749-18-022299","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022299/rdgdoc.xml","form_type":"4"}},{"id":3804208,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T20:46:18.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":1956,"price":1.76,"value":3442.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $1.76 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 28, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 14,579 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":15721,"source":{"system":"sec-edgar","filing":"0001534424-18-000339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000339/ownership.xml","form_type":"4"}},{"id":3874583,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T20:10:47.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":1578,"price":2.18,"value":3440.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.18 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 29, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 12,623 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":13765,"source":{"system":"sec-edgar","filing":"0001534424-18-000242","document":"spencer.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000242/spencer.xml","form_type":"4"}},{"id":3898238,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-11T12:55:08.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2019 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.18,"expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-18-000210","document":"spencer.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000210/spencer.xml","form_type":"4"}},{"id":3976195,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T21:00:30.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":1097,"price":3.13,"value":3433.61,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.13 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 29, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 11,045 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":12187,"source":{"system":"sec-edgar","filing":"0001534424-18-000115","document":"spencer.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000115/spencer.xml","form_type":"4"}},{"id":4088023,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-26T21:07:14.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":1940,"price":2.75,"value":5335.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.75 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 29, 2017."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 9,948 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":11090,"source":{"system":"sec-edgar","filing":"0001534424-18-000029","document":"spencer.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000029/spencer.xml","form_type":"4"}},{"id":4123007,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock Purchase Option","published_at":"2017-12-22T16:25:39.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":240000,"derivative":{"exercise_price":0.05,"expiration_date":"2027-12-20","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001437749-17-021100","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774917021100/rdgdoc.xml","form_type":"4"}},{"id":4131521,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-12-14T21:26:15.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2018 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.75,"expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-17-000503","document":"spencer.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442417000503/spencer.xml","form_type":"4"}},{"id":4190913,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-05T20:15:32.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":2022,"price":2.47,"value":4994.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 29, 2017."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 8,008 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":9150,"source":{"system":"sec-edgar","filing":"0001534424-17-000417","document":"spencer.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442417000417/spencer.xml","form_type":"4"}},{"id":4507436,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T21:49:55.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":1896,"price":2.64,"value":5005.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $2.64 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 30, 2016."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 5,986 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":7128,"source":{"system":"sec-edgar","filing":"0001534424-17-000011","document":"spencer.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442417000011/spencer.xml","form_type":"4"}},{"id":4521232,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock Purchase Option","published_at":"2016-12-15T21:37:10.000Z","date":"2016-12-13","kind":"grant","acquired":true,"shares":123500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":123500,"derivative":{"exercise_price":0.0652,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":123500},"source":{"system":"sec-edgar","filing":"0001437749-16-043432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774916043432/rdgdoc.xml","form_type":"4"}},{"id":4586478,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-04T20:37:10.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":701,"price":6.65,"value":4661.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $6.65 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2016."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 4,090 shares held jointly with spouse and 510 shares held in an IRA."}],"balance_after":5232,"source":{"system":"sec-edgar","filing":"0001534424-16-001073","document":"spencer.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442416001073/spencer.xml","form_type":"4"}}]}